MedTrace Logo

Tissue Engineered Nasal Cartilage for Regeneration of Articular Cartilage

NCT01605201 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2018-08-27

No results posted yet for this study

Summary

The purpose of this study is to investigate the safety and feasibility of implanting an engineered cartilage graft obtained by culturing expanded autologous nasal chondrocytes within a collagen type I/III membrane into the cartilage defect on the femoral condyle and/or trochlea of the knee after a traumatic injury.

Conditions

  • Cartilage Lesion
  • Degenerative Lesion of Articular Cartilage of Knee

Interventions

BIOLOGICAL

Tissue engineered cartilage graft

Autologous nasal chondrocytes expanded in vitro and cultured in a collagen type I//III scaffold

Sponsors & Collaborators

  • Deutsche Arthrose-Hilfe

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Marcel Jakob, Prof. Dr. · University Hospital, Basel, Switzerland

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-29
Primary Completion
2018-08-15
Completion
2018-08-15

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01605201 on ClinicalTrials.gov